Robuta

https://www.gov.uk/guidance/manual-of-patent-practice-mopp/section-53-compulsory-licences-supplementary-provisions Manual of Patent Practice - Section 53: Compulsory licences; supplementary provisions - Guidance -... Sections (53.01 - 53.06) last updated: April 2015. section 53 compulsory licences manual patent practice https://www.rug.nl/rechten/onderzoek/expertisecentra/gchl/blog/the-most-common-misunderstanding-about-compulsory-licences?lang=en The Most Common Misunderstanding About Compulsory Licences | Groningen Centre for Health Law |... the most common misunderstanding compulsory licences https://www.gov.uk/guidance/manual-of-patent-practice-mopp/section-48b-compulsory-licences-other-cases Manual of Patent Practice - Section 48B: Compulsory licences: other cases - Guidance - GOV.UK Sections (48B.01 - 48B.17) last updated: July 2021. https://www.gov.uk/guidance/the-patent-act-1977/section-128a-supplemental-eu-compulsory-licences The Patents Act 1977 (as amended) - Section 128A: Compulsory pharmaceutical licences - Guidance -... patents act https://www.gov.uk/guidance/manual-of-patent-practice-mopp/section-48a-compulsory-licences-wto-proprietors Manual of Patent Practice - Section 48A: Compulsory licences: WTO proprietors - Guidance - GOV.UK Sections (48A.01-48A.09) last updated: July 2021. https://www.downtoearth.org.in/health/big-pharma-and-intellectual-property-why-is-india-afraid-of-compulsory-licences--77470 Big Pharma and intellectual property: Why is India afraid of compulsory licences? While rich nations are discovering the virtues of compulsory drug licences, India has resolutely turned its back on this tool despite nudges from the court big pharma intellectual property